サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：ヒトミルクオリゴ糖（HMO）市場、シェア、規模、動向、産業分析レポート：タイプ別；用途別；流通経路別；地域別；セグメント予測、2023～2032年
市場調査レポート
商品コード
1346940

ヒトミルクオリゴ糖（HMO）市場、シェア、規模、動向、産業分析レポート：タイプ別；用途別；流通経路別；地域別；セグメント予測、2023～2032年

Human Milk Oligosaccharides (HMO) Market Share, Size, Trends, Industry Analysis Report, By Type (2'FL, 3'FL, 3'SL, 6'SL); By Application; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 118 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ヒトミルクオリゴ糖（HMO）市場、シェア、規模、動向、産業分析レポート：タイプ別；用途別；流通経路別；地域別；セグメント予測、2023～2032年
出版日: 2023年08月23日
発行: Polaris Market Research
ページ情報: 英文 118 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の新しい調査によると、世界のヒトミルクオリゴ糖（HMO）市場規模は2032年までに17億9,996万米ドルに達すると予測されています。このレポートは現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

ヒトミルクオリゴ糖（HMOs）は、ヒト母乳中に天然に存在する複合炭水化物または糖です。HMOはヒトの母乳に特有であり、牛の母乳を含む他の哺乳類の母乳には相当量存在しません。

HMOは乳児の栄養源として機能しますが、赤ちゃんが直接消化することはありません。その代わり、HMOはプレバイオティクスとして働き、乳児の腸内の有益な細菌の餌となります。腸内細菌叢は、免疫系の発達、消化、および全体的な健康において極めて重要です。HMOは、有害な病原体の増殖を抑制しながら、ビフィズス菌のような特定の有益な細菌の増殖を選択的に促進します。

ヒトミルクオリゴ糖（HMOs）はヒト母乳の必須成分であり、様々な濃度と組成で入手可能です。HMOのユニークな性質は、その使用に特定の規制認可を必要とします。米国では、オリゴ糖は栄養補助食品に分類されるよりもむしろ食品に組み入れられることが認可されており、一般に安全と認められる（GRAS）規制の対象です。

例えば、GRAS認可のHMO製品ラインは、デュポン社が開発したCARE4Uであり、乳児用調製粉乳と幼児用食品に利用されています。この承認により、消費に対する安全性が保証されます。さらに、HMOの需要の増大は、その使用について欧州委員会からの支持を求めるための斬新な食品安全性評価につながっています。

ヒトミルクオリゴ糖（HMOs）の世界の採用が増加しています。2022年1月に発表された世界経済フォーラムの記事によると、2020年の日本の出生数は前年比2.8%減少し、1899年以来最低を記録しました。

HMOの需要の増加は、ライフスタイルの改善と健康とウェルネスへの関心の高まりに起因します。HMOは、障害に対処しリスクの高い健康状態を緩和するために、機能性飲食品および食品サプリメントに利用されます。この要因は、世界のHMO産業の成長に大きく寄与しています。しかしながら、HMO製品に関連する高コストは、予測期間中、市場成長の大きな課題となることが予想されます。

COVID-19パンデミックはHMO産業に大きな影響を与えました。パンデミックの初期には、消費者が家庭で消費するためにパニック買いに従事したため、HMOの需要が急増しました。その結果、免疫強化製品とされるHMOの売上が増加しました。

ヒトミルクオリゴ糖（HMO）市場レポート・ハイライト

2022年には、乳児用調製粉乳設計におけるHMOの需要増加により、乳児用調製粉乳分野が最大の市場シェアを占めました。HMOはプレバイオティクス効果、感染予防、記憶力強化、腸の健康維持、脳の発達などの有益な特性を提供します。これらの要因は、乳児用調製粉乳におけるHMOの需要を促進します。

2022年には、ドラッグストアまたは薬局セグメントがヒトミルクオリゴ糖市場で最も高い市場シェアを占め、成長し続けると予測されます。これは主に、通信販売業者やスーパーセンターとの競争が激化する中、このセグメントが顧客の獲得と維持に重点を置いているためです。

アジア太平洋地域では、乳児の栄養と全体的な健康におけるHMOの利点に対する意識の高まりにより、ヒトミルクオリゴ糖（HMO）市場が大きく成長すると予想されます。消費者がより健康志向になり、乳児のために高品質の栄養オプションを求めるようになるにつれて、HMOの需要は増加すると予想されます。

Elicityl S.A.、Abbott Laboratories、Biosynth Carbosynth、Dextra Laboratories Ltd.、Dupont Nutrition &Biosciences、Glycosyn、BASF S.E.、Glycom A/S、Nestle Health Science、Neolacta Lifesciences Pvt.Ltd.、Royal DSM、Medolac Laboratories、Chr. Hansen Holding A/S、ZuChem、Inbiose NV、Royal FrieslandCampina N.V.を含む、世界的に存在感を示す世界のヒト乳オリゴ糖業界のプレーヤー。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の母乳オリゴ糖（HMO）市場洞察

  • 母乳オリゴ糖（HMO）- 業界スナップショット
  • 母乳オリゴ糖（HMO）市場力学
    • 促進要因と機会
      • 乳児人口の増加
      • 母乳育児の重要性に対する意識の高まり
    • 抑制要因と課題
      • 限られた可用性
  • PESTEL分析
  • 母乳オリゴ糖（HMO）市場の業界動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界の母乳オリゴ糖（HMO）市場、種類別

  • 主な調査結果
  • イントロダクション
  • 2'FL
  • 3'FL
  • 3'SL
  • 6'SL

第6章 世界の母乳オリゴ糖（HMO）市場、用途別

  • 主な調査結果
  • イントロダクション
  • 乳児用調製粉乳
  • 機能性飲食品
  • 栄養補助食品

第7章 世界のヒト乳オリゴ糖（HMO）市場、流通チャネル別

  • 主な調査結果
  • イントロダクション
  • ハイパーマーケットとスーパーマーケット
  • ドラッグストアまたは薬局
  • オンライン販売チャネル
  • その他

第8章 世界の母乳オリゴ糖（HMO）市場、地域

  • 主な調査結果
  • イントロダクション
    • 母乳オリゴ糖（HMO）市場評価、地域、2019-2032
  • 母乳オリゴ糖（HMO）市場-北米
    • 北米：ヒトミルクオリゴ糖（HMO）市場、タイプ別、2019年から2032年
    • 北米：ヒトミルクオリゴ糖（HMO）市場、流通チャネル別、2019年～2032年
    • 北米：ヒトミルクオリゴ糖（HMO）市場、用途別、2019年～2032年
    • 母乳オリゴ糖（HMO）市場-米国
    • 母乳オリゴ糖（HMO）市場- カナダ
  • 母乳オリゴ糖（HMO）市場- 欧州
    • 欧州：母乳オリゴ糖（HMO）市場、種類別、2019～2032年
    • 欧州：ヒトミルクオリゴ糖（HMO）市場、流通チャネル別、2019～2032年
    • 欧州：母乳オリゴ糖（HMO）市場、用途別、2019～2032年
    • 母乳オリゴ糖（HMO）市場- 英国
    • 母乳オリゴ糖（HMO）市場- フランス
    • 母乳オリゴ糖（HMO）市場- ドイツ
    • 母乳オリゴ糖（HMO）市場- イタリア
    • 母乳オリゴ糖（HMO）市場- スペイン
    • 母乳オリゴ糖（HMO）市場- オランダ
    • 人乳オリゴ糖（HMO）市場- ロシア
  • 母乳オリゴ糖（HMO）市場- アジア太平洋
    • アジア太平洋地域：母乳オリゴ糖（HMO）市場、種類別、2019～2032年
    • アジア太平洋：母乳オリゴ糖（HMO）市場、流通チャネル別、2019～2032年
    • アジア太平洋地域：母乳オリゴ糖（HMO）市場、用途別、2019～2032年
    • 母乳オリゴ糖（HMO）市場- 中国
    • 母乳オリゴ糖（HMO）市場- インド
    • 母乳オリゴ糖（HMO）市場- マレーシア
    • 母乳オリゴ糖（HMO）市場- 日本
    • 人乳オリゴ糖（HMO）市場- インドネシア
    • 母乳オリゴ糖（HMO）市場- 韓国
  • 母乳オリゴ糖（HMO）市場-中東およびアフリカ
    • 中東およびアフリカ：母乳オリゴ糖（HMO）市場、種類別、2019～2032年
    • 中東およびアフリカ：母乳オリゴ糖（HMO）市場、流通チャネル別、2019～2032年
    • 中東およびアフリカ：母乳オリゴ糖（HMO）市場、用途別、2019～2032年
    • 母乳オリゴ糖（HMO）市場- サウジアラビア
    • 母乳オリゴ糖（HMO）市場- アラブ首長国連邦
    • 母乳オリゴ糖（HMO）市場- イスラエル
    • 母乳オリゴ糖（HMO）市場- 南アフリカ
  • 母乳オリゴ糖（HMO）市場-ラテンアメリカ
    • ラテンアメリカ：ヒトミルクオリゴ糖（HMO）市場、タイプ別、2019年から2032年
    • ラテンアメリカ：ヒトミルクオリゴ糖（HMO）市場、流通チャネル別、2019-2032
    • ラテンアメリカ：ヒトミルクオリゴ糖（HMO）市場、用途別、2019年から2032年
    • 母乳オリゴ糖（HMO）市場- メキシコ
    • 母乳オリゴ糖（HMO）市場- ブラジル
    • 母乳オリゴ糖（HMO）市場- アルゼンチン

第9章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Abbott Laboratories
  • BASF S.E
  • Biosynth Carbosynth
  • Chr. Hansen Holding A/S
  • Dextra Laboratories Ltd
  • Dupont Nutrition & Biosciences
  • Elicityl S.A.
  • Glycom A/S
  • Glycosyn
  • Inbiose NV
  • Medolac Laboratories
  • Neolacta Lifesciences Pvt. Ltd
  • Nestle Health Science
  • Royal DSM
  • Royal FrieslandCampina N.V
  • ZuChem
図表

List of Tables

  • Table 1 Global Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 2 Global Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 3 Global Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 4 Human Milk Oligosaccharides (HMO) Market Assessment, By Geography, 2019 - 2032 (USD Million)
  • Table 5 North America: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 6 North America: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 7 North America: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 8 U.S.: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 9 U.S.: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 10 U.S.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 11 Canada: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 12 Canada: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 13 Canada: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 14 Europe: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 15 Europe: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 16 Europe: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 17 UK: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 18 UK: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 19 UK: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 20 France: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 21 France: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 22 France: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 23 Germany: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 24 Germany: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 25 Germany: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 26 Italy: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 27 Italy: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 28 Italy: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 29 Spain: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 30 Spain: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 31 Spain: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 32 Netherlands: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 33 Netherlands: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 34 Netherlands: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 35 Russia: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 36 Russia: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 37 Russia: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 38 Asia Pacific: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 39 Asia Pacific: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 40 Asia Pacific: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 41 China: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 42 China: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 43 China: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 44 India: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 45 India: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 46 India: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 47 Malaysia: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 48 Malaysia: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 49 Malaysia: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 50 Japan: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 51 Japan: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 52 Japan: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 53 Indonesia: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 54 Indonesia: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 55 Indonesia: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 56 South Korea: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 57 South Korea: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 58 South Korea: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 59 Middle East & Africa: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 60 Middle East & Africa: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 61 Middle East & Africa: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 62 Saudi Arabia: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 63 Saudi Arabia: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 64 Saudi Arabia: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 65 UAE: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 66 UAE: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 67 UAE: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 68 Israel: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 69 Israel: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 70 Israel: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 71 South Africa: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 72 South Africa: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 73 South Africa: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 74 Latin America: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 75 Latin America: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 76 Latin America: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 77 Mexico: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 78 Mexico: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 79 Mexico: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 80 Brazil: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 81 Brazil: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 82 Brazil: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 83 Argentina: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 84 Argentina: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 85 Argentina: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)

List of Figures

  • Figure 1. Global Human Milk Oligosaccharides (HMO) Market, 2019 - 2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Application
  • Figure 7. Global Human Milk Oligosaccharides (HMO) Market, by Application, 2023 & 2032 (USD Million)
  • Figure 8. Market by Type
  • Figure 9. Global Human Milk Oligosaccharides (HMO) Market, by Type, 2023 & 2032 (USD Million)
  • Figure 10. Market by Distribution channel
  • Figure 11. Global Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2023 & 2032 (USD Million)
  • Figure 12. Human Milk Oligosaccharides (HMO) Market Assessment, By Geography, 2019 - 2032 (USD Million)
  • Figure 13. Strategic Analysis - Human Milk Oligosaccharides (HMO) Market
目次
Product Code: PM2516

The global human milk oligosaccharides (HMO) market size is expected to reach USD 1,799.96 million by 2032, according to a new study by Polaris Market Research. The report "Human Milk Oligosaccharides (HMO) Market Share, Size, Trends, Industry Analysis Report, By Type (2'FL, 3'FL, 3'SL, 6'SL); By Application; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Human Milk Oligosaccharides (HMOs) are complex carbohydrates or sugars naturally found in human breast milk. HMOs are unique to human milk and are not present in significant amounts in other mammalian milk, including cow's milk.

HMOs serve as a source of infant nutrition, although the baby does not directly digest them. Instead, they act as prebiotics, which means they serve as food for beneficial bacteria in the infant's gut. The gut microbiota is crucial in immune system development, digestion, and overall health. HMOs selectively promote the growth of specific beneficial bacteria, such as Bifidobacteria, while inhibiting the growth of harmful pathogens.

Human Milk Oligosaccharides (HMOs) are essential constituents of human breast milk and are available in various concentrations and compositions. The unique nature of HMOs requires specific regulatory approvals for their use. In the United States, oligosaccharides are authorized to be incorporated into food products rather than categorized as dietary supplements and are subject to the Generally Recognized as Safe (GRAS) regulations.

For instance, the GRAS-approved HMO product line is CARE4U, developed by DuPont, which is utilized in infant formula and toddler foods. This approval ensures its safety for consumption. Furthermore, the growing demand for HMOs has led to a novel food safety assessment to seek support from the European Commission for their usage.

The global adoption of Human Milk Oligosaccharides (HMOs) has increased. According to a World Economic Forum article published in January 2022, the number of births in Japan decreased by 2.8% in 2020 compared to the previous year, reaching its lowest point since 1899.

The increasing demand for HMOs can be attributed to lifestyle improvements and a growing focus on health and wellness. HMOs are utilized in functional food and beverage products and food supplements to address disorders and mitigate high-risk health conditions. This factor has significantly contributed to the growth of the global HMO industry. However, the high costs associated with HMO products are expected to pose a major challenge to market growth during the forecast period.

The COVID-19 pandemic has had a significant impact on the HMO industry. During the initial phase of the pandemic, there was a surge in demand for HMOs as consumers engaged in panic buying for at-home consumption. It resulted in increased sales of HMOs, considered immune-boosting products.

Human Milk Oligosaccharides (HMO) Market Report Highlights

In 2022, the infant formula segment accounted for the largest market share due to the increasing demand for HMOs in infant formula design. HMOs offer beneficial properties like prebiotic effects, infection prevention, memory enhancement, gut health maintenance, and brain development. These factors drive the demand for HMOs in infant formulas.

In 2022, the drug store or pharmacy segment held the highest market share in the Human Milk Oligosaccharides market and is projected to continue growing. It is primarily due to the segment's focus on attracting and retaining customers amidst rising competition from mail-order retailers and supercenters.

The Asia Pacific region expected to witness significant growth in the Human Milk Oligosaccharides (HMO) market due to growing awareness of the benefits of HMOs in infant nutrition and overall health in the region. As consumers become more health-conscious and seek high-quality nutrition options for their infants, the demand for HMOs is expected to rise.

The global Human Milk Oligosaccharides industry players with a global presence including Elicityl S.A., Abbott Laboratories, Biosynth Carbosynth, Dextra Laboratories Ltd., Dupont Nutrition & Biosciences, Glycosyn, BASF S.E., Glycom A/S, Nestle Health Science, Neolacta Lifesciences Pvt. Ltd, Royal DSM, Medolac Laboratories, Chr. Hansen Holding A/S, ZuChem, Inbiose NV, and Royal FrieslandCampina N.V.

Polaris Market Research has segmented the human milk oligosaccharides (HMO) market report based on type, application, distribution channel, and region:

Human Milk Oligosaccharides (HMO), Type Outlook (Revenue - USD Million, 2019 - 2032)

  • 2'FL
  • 3'FL
  • 3'SL
  • 6'SL

Human Milk Oligosaccharides (HMO), Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Infant Formula
  • Functional Food & Beverage
  • Food Supplements

Human Milk Oligosaccharides (HMO), Distribution Channel Outlook (Revenue - USD Million, 2019 - 2032)

  • Hypermarkets & Supermarkets
  • Drug Store or Pharmacy
  • Online Sales Channel
  • Others

Fogless Mirror, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Netherlands
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Indonesia
    • Malaysia
  • Latin America
    • Argentina
    • Brazil
    • Mexico
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Israel
    • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Human Milk Oligosaccharides (HMO) Market Insights

  • 4.1. Human Milk Oligosaccharides (HMO) - Industry Snapshot
  • 4.2. Human Milk Oligosaccharides (HMO) Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increase in the infant population
      • 4.2.1.2. Growing awareness of the importance of breastfeeding
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Limited availability
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Human Milk Oligosaccharides (HMO) Market Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Human Milk Oligosaccharides (HMO) Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • 5.3. 2'FL
    • 5.3.1. Global Human Milk Oligosaccharides (HMO) Market, by 2'FL, by Region, 2019 - 2032 (USD Million)
  • 5.4. 3'FL
    • 5.4.1. Global Human Milk Oligosaccharides (HMO) Market, by 3'FL, by Region, 2019 - 2032 (USD Million)
  • 5.5. 3'SL
    • 5.5.1. Global Human Milk Oligosaccharides (HMO) Market, by 3'SL, by Region, 2019 - 2032 (USD Million)
  • 5.6. 6'SL
    • 5.6.1. Global Human Milk Oligosaccharides (HMO) Market, by 6'SL, by Region, 2019 - 2032 (USD Million)

6. Global Human Milk Oligosaccharides (HMO) Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • 6.3. Infant Formula
    • 6.3.1. Global Human Milk Oligosaccharides (HMO) Market, by Infant Formula, by Region, 2019 - 2032 (USD Million)
  • 6.4. Functional Food & Beverage
    • 6.4.1. Global Human Milk Oligosaccharides (HMO) Market, by Functional Food & Beverage, by Region, 2019 - 2032 (USD Million)
  • 6.5. Food Supplements
    • 6.5.1. Global Human Milk Oligosaccharides (HMO) Market, by Food Supplements, by Region, 2019 - 2032 (USD Million)

7. Global Human Milk Oligosaccharides (HMO) Market, by Distribution channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • 7.3. Hypermarkets & Supermarkets
    • 7.3.1. Global Human Milk Oligosaccharides (HMO) Market, by Hypermarkets & Supermarkets, by Region, 2019 - 2032 (USD Million)
  • 7.4. Drug Store or Pharmacy
    • 7.4.1. Global Human Milk Oligosaccharides (HMO) Market, by Drug Store or Pharmacy, by Region, 2019 - 2032 (USD Million)
  • 7.5. Online Sales Channel
    • 7.5.1. Global Human Milk Oligosaccharides (HMO) Market, by Online Sales Channel, by Region, 2019 - 2032 (USD Million)
  • 7.6. Others
    • 7.6.1. Global Human Milk Oligosaccharides (HMO) Market, by Others, by Region, 2019 - 2032 (USD Million)

8. Global Human Milk Oligosaccharides (HMO) Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Human Milk Oligosaccharides (HMO) Market Assessment, By Geography, 2019 - 2032 (USD Million)
  • 8.3. Human Milk Oligosaccharides (HMO) Market - North America
    • 8.3.1. North America: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
    • 8.3.2. North America: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
    • 8.3.3. North America: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.3.4. Human Milk Oligosaccharides (HMO) Market - U.S.
      • 8.3.4.1. U.S.: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.3.4.2. U.S.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.3.4.3. U.S.: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.3.5. Human Milk Oligosaccharides (HMO) Market - Canada
      • 8.3.5.1. Canada: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.3.5.2. Canada.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.3.5.3. Canada: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • 8.4. Human Milk Oligosaccharides (HMO) Market - Europe
    • 8.4.1. Europe: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
    • 8.4.2. Europe.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
    • 8.4.3. Europe: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.4. Human Milk Oligosaccharides (HMO) Market - UK
      • 8.4.4.1. UK: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.4.2. UK.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.4.4.3. UK: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.5. Human Milk Oligosaccharides (HMO) Market - France
      • 8.4.5.1. France: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.5.2. France.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.4.5.3. France: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.6. Human Milk Oligosaccharides (HMO) Market - Germany
      • 8.4.6.1. Germany: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.6.2. Germany.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.4.6.3. Germany: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.7. Human Milk Oligosaccharides (HMO) Market - Italy
      • 8.4.7.1. Italy: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.7.2. Italy.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.4.7.3. Italy: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.8. Human Milk Oligosaccharides (HMO) Market - Spain
      • 8.4.8.1. Spain: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.8.2. Spain.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.4.8.3. Spain: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.9. Human Milk Oligosaccharides (HMO) Market - Netherlands
      • 8.4.9.1. Netherlands: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.9.2. Netherlands.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.4.9.3. Netherlands: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.10. Human Milk Oligosaccharides (HMO) Market - Russia
      • 8.4.10.1. Russia: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.10.2. Russia.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.4.10.3. Russia: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • 8.5. Human Milk Oligosaccharides (HMO) Market - Asia Pacific
    • 8.5.1. Asia Pacific: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
    • 8.5.2. Asia Pacific.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
    • 8.5.3. Asia Pacific: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.4. Human Milk Oligosaccharides (HMO) Market - China
      • 8.5.4.1. China: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.4.2. China.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.5.4.3. China: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.5. Human Milk Oligosaccharides (HMO) Market - India
      • 8.5.5.1. India: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.5.2. India.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.5.5.3. India: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.6. Human Milk Oligosaccharides (HMO) Market - Malaysia
      • 8.5.6.1. Malaysia: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.6.2. Malaysia.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.5.6.3. Malaysia: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.7. Human Milk Oligosaccharides (HMO) Market - Japan
      • 8.5.7.1. Japan: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.7.2. Japan.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.5.7.3. Japan: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.8. Human Milk Oligosaccharides (HMO) Market - Indonesia
      • 8.5.8.1. Indonesia: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.8.2. Indonesia.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.5.8.3. Indonesia: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.9. Human Milk Oligosaccharides (HMO) Market - South Korea
      • 8.5.9.1. South Korea: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.9.2. South Korea.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.5.9.3. South Korea: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • 8.6. Human Milk Oligosaccharides (HMO) Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
    • 8.6.3. Middle East & Africa: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.6.4. Human Milk Oligosaccharides (HMO) Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.6.5. Human Milk Oligosaccharides (HMO) Market - UAE
      • 8.6.5.1. UAE: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.6.5.2. UAE.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.6.5.3. UAE: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.6.6. Human Milk Oligosaccharides (HMO) Market - Israel
      • 8.6.6.1. Israel: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.6.6.2. Israel.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.6.6.3. Israel: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.6.7. Human Milk Oligosaccharides (HMO) Market - South Africa
      • 8.6.7.1. South Africa: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.6.7.2. South Africa.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.6.7.3. South Africa: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • 8.7. Human Milk Oligosaccharides (HMO) Market - Latin America
    • 8.7.1. Latin America: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
    • 8.7.2. Latin America.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
    • 8.7.3. Latin America: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.7.4. Human Milk Oligosaccharides (HMO) Market - Mexico
      • 8.7.4.1. Mexico: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.7.4.2. Mexico.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.7.4.3. Mexico: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.7.5. Human Milk Oligosaccharides (HMO) Market - Brazil
      • 8.7.5.1. Brazil: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.7.5.2. Brazil.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.7.5.3. Brazil: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.7.6. Human Milk Oligosaccharides (HMO) Market - Argentina
      • 8.7.6.1. Argentina: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.7.6.2. Argentina.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.7.6.3. Argentina: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott Laboratories
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. BASF S.E
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Biosynth Carbosynth
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Chr. Hansen Holding A/S
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Dextra Laboratories Ltd
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Dupont Nutrition & Biosciences
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Elicityl S.A.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Glycom A/S
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Glycosyn
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Inbiose NV
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Medolac Laboratories
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Neolacta Lifesciences Pvt. Ltd
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Nestle Health Science
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Royal DSM
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Royal FrieslandCampina N.V
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development
  • 10.16. ZuChem
    • 10.16.1. Company Overview
    • 10.16.2. Financial Performance
    • 10.16.3. Product Benchmarking
    • 10.16.4. Recent Development